Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI – Free Report) shares are scheduled to reverse split before the market opens on Tuesday, May 21st. The 1-10 reverse split was announced on Tuesday, May 21st. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, May 21st.
Scinai Immunotherapeutics Stock Performance
Scinai Immunotherapeutics stock opened at $0.45 on Thursday. The company has a 50 day moving average price of $0.48 and a 200-day moving average price of $0.56. Scinai Immunotherapeutics has a fifty-two week low of $0.43 and a fifty-two week high of $2.27. The company has a market capitalization of $841,313.00, a PE ratio of -0.14 and a beta of 2.45.
Scinai Immunotherapeutics Company Profile
Featured Articles
- Five stocks we like better than Scinai Immunotherapeutics
- Manufacturing Stocks Investing
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Invest in the FAANG Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Scinai Immunotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scinai Immunotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.